Characterization of the antibody response against Plasmodium falciparum erythrocyte membrane protein 1 in human volunteers

Infection and Immunity

Volumn 75, Issue 12, 2007, Pages 5967-5973

  Krause, Darren R ^a,b   Gatton, Michelle L ^a   Frankland, Sarah ^c   Eisen, Damon P ^d   Good, Michael F ^a   Tilley, Leann ^c   Cheng, Qin ^a,b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b AUSTRALIAN ARMY MALARIA INSTITUTE   (Australia)

^c LA TROBE UNIVERSITY   (Australia)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DUFFY BINDING PROTEIN; ERYTHROCYTE BAND 3 PROTEIN; ERYTHROCYTE MEMBRANE PROTEIN 1; HYBRID PROTEIN; IMMUNOGLOBULIN G; PARASITE ANTIGEN; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN RECOGNITION; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CROSS REACTION; HEMAGGLUTINATION; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; MALARIA FALCIPARUM; NORMAL HUMAN; PARASITEMIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN DOMAIN;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ERYTHROCYTES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALARIA, FALCIPARUM; PARASITEMIA; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; RECEPTORS, CELL SURFACE; ROSETTE FORMATION; TRAVEL;

EID: 36749027615     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00327-07     Document Type: Article

References (49)

1. Barragan, A., V. Fernandez, Q. Chen, A. von Euler, M. Wahlgren, and D. Spillmann. 2000. The duffy-binding-like domain 1 of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) is a heparan sulfate ligand that requires 12 mers for binding. Blood 95:3594-3599.
2. Baruch, D. I., X. C. Ma, H. B. Singh, X. Bi, B. L. Pasloske, and R. J. Howard. 1997. Identification of a region of PfEMP1 that mediates adherence of Plasmodium falciparum infected erythrocytes to CD36: conserved function with variant sequence. Blood 90:3766-3775.
3. Beeson, J. G., E. J. Mann, T. J. Byrne, A. Caragounis, S. R. Elliott, G. V. Brown, and S. J. Rogerson. 2006. Antigenic differences and conservation among placental Plasmodium falciparum-infected erythrocytes and acquisition of variant-specific and cross-reactive antibodies. J. Infect. Dis. 193:721-730.
4. Bruce-Chwatt, L. J. 1952. Malaria in African infants and children in southern Nigeria. Ann. Trop. Med. Parasitol. 46:173-200.
5. Buffet, P. A., B. Gamain, C. Scheidig, D. Baruch, J. D. Smith, R. Hernandez-Rivas, B. Pouvelle, S. Oishi, N. Fujii, T. Fusai, D. Parzy, L. H. Miller, J. Gysin, and A. Scherf. 1999. Plasmodium falciparum domain mediating adhesion to chondroitin sulfate A: a receptor for human placental infection. Proc. Natl. Acad. Sci. USA 96:12743-12748.
6. Bull, P. C., B. S. Lowe, M. Kortok, and K. Marsh. 1999. Antibody recognition of Plasmodium falciparum erythrocyte surface antigens in Kenya: evidence for rare and prevalent variants. Infect. Immun. 67:733-739.
7. Bull, P. C., B. S. Lowe, M. Kortok, C. S. Molyneux, C. I. Newbold, and K. Marsh. 1998. Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nat. Med. 4:358-360.
8. Chen, Q., A. Barragan, V. Fernandez, A. Sundstrom, M. Schlichtherle, A. Sahlen, J. Carlson, S. Datta, and M. Wahlgren. 1998. Identification of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) as the resetting ligand of the malaria parasite P. falciparum. J. Exp. Med. 187:15-23.
9. Cheng, Q., G. Lawrence, C. Reed, A. Stowers, L. Ranford-Cartwright, A. Creasey, R. Carter, and A. Saul. 1997. Measurement of Plasmodium falciparum growth rates in vivo: a test of malaria vaccines. Am. J. Trop. Med. Hyg. 57:495-500.
10. Collins, W. E., and G. M. Jeffery. 1999. A retrospective examination of secondary sporozoite- and trophozoite-induced infections with Plasmodium falciparum: development of parasitologic and clinical immunity following secondary infection. Am. J. Trop. Med. Hyg. 61:20-35.
11. Curtin, P. D. 1994. Malarial immunities in nineteenth-century west Africa and the Caribbean. Parassitologia 36:69-82.
12. Dodoo, D., T. Staalsoe, H. Giha, J. A. Kurtzhals, B. D. Akanmori, K. Koram, S. Dunyo, F. K. Nkrumah, L. Hviid, and T. G. Theander. 2001. Antibodies to variant antigens on the surfaces of infected erythrocytes are associated with protection from malaria in Ghanaian children. Infect. Immun. 69:3713-3718.
13. Dubois, P., P. Druilhe, D. Arriat, M. Jendoubi, and H. Jouin. 1987. Changes in recognition of Plasmodium falciparum antigens by human sera depending on previous malaria exposure. Ann. Inst. Pasteur Immunol. 138:383-396.
14. Elliott, S. R., P. D. Payne, M. F. Duffy, T. J. Byrne, W. H. Tham, S. J. Rogerson, G. V. Brown, and D. P. Eisen. 2007. Antibody recognition of heterologous variant surface antigens after a single Plasmodium falciparum infection in previously naive adults. Am. J. Trop. Med. Hyg. 76:860-864.
15. Frankland, S., A. Adisa, P. Horrocks, T. F. Taraschi, T. Schneider, S. R. Elliott, S. J. Rogerson, E. Knuepfer, A. F. Cowman, C. I. Newbold, and L. Tilley. 2006. Delivery of the malaria virulence protein PfEMP1 to the erythrocyte surface requires cholesterol-rich domains. Eukaryot. Cell 5:849-860.
16. Fried, M., and P. E. Duffy. 1996. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 272:1502-1504.
17. Fruh, K., O. Doumbo, H. M. Muller, O. Koita, J. McBride, A. Crisanti, Y. Toure, and H. Bujard. 1991. Human antibody response to the major merozoite surface antigen of Plasmodium falciparum is strain specific and short-lived. Infect. Immun. 59:1319-1324.
18. Gamain, B., J. D. Smith, M. Avril, D. I. Baruch, A. Scherf, J. Gysin, and L. H. Miller. 2004. Identification of a 67-amino-acid region of the Plasmodium falciparum variant surface antigen that binds chondroitin sulphate A and elicits antibodies reactive with the surface of placental isolates. Mol. Microbiol. 53:445-455.
19. Gardner, M. J., N. Hall, E. Fung, O. White, M. Berriman, R. W. Hyman, J. M. Carlton, A. Pain, K. E. Nelson, S. Bowman, I. T. Paulsen, K. James, J. A. Eisen, K. Rutherford, S. L. Salzberg, A. Craig, S. Kyes, M. S. Chan, V. Nene, S. J. Shallom, B. Suh, J. Peterson, S. Angiuoli, M. Pertea, J. Allen, J. Selengut, D. Haft, M. W. Mather, A. B. Vaidya, D. M. Martin, A. H. Fairlamb, M. J. Fraunholz, D. S. Roos, S. A. Ralph, G. I. McFadden, L. M. Cummings, G. M. Subramanian, C. Mungall, J. C. Venter, D. J. Carucci, S. L. Hoffman, C. Newbold, R. W. Davis, C. M. Fraser, and B. Barrell. 2002. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419:498-511.
20. Giha, H. A., T. Staalsoe, D. Dodoo, I. M. Elhassan, C. Roper, G. M. Satti, D. E. Arnot, L. Hviid, and T. G. Theander. 1999. Overlapping antigenic repertoires of variant antigens expressed on the surface of erythrocytes infected by Plasmodium falciparum. Parasitology 119:7-17.
21. Giha, H. A., T. Staalsoe, D. Dodoo, I. M. Elhassan, C. Roper, G. M. Satti, D. E. Arnot, T. G. Theander, and L. Hviid. 1999. Nine-year longitudinal study of antibodies to variant antigens on the surface of Plasmodium falciparum-infected erythrocytes. Infect. Immun. 67:4092-4098.
22. Giha, H. A., T. Staalsoe, D. Dodoo, C. Roper, G. M. Satti, D. E. Arnot, L. Hviid, and T. G. Theander. 2000. Antibodies to variable Plasmodium falciparum-infected erythrocyte surface antigens are associated with protection from novel malaria infections. Immunol. Lett. 71:117-126.
23. Giha, H. A., T. G. Theander, T. Staalso, C. Roper, I. M. Elhassan, H. Babiker, G. M. Satti, D. E. Arnot, and L. Hviid. 1998. Seasonal variation in agglutination of Plasmodium falciparum-infected erythrocytes. Am. J. Trop. Med. Hyg. 58:399-405.
24. Gratepanche, S., B. Gamain, J. D. Smith, B. A. Robinson, A. Saul, and L. H. Miller. 2003. Induction of crossreactive antibodies against the Plasmodium falciparum variant protein. Proc. Natl. Acad. Sci. USA 100:13007-13012.
25. Kinyanjui, S. M., P. Bull, C. I. Newbold, and K. Marsh. 2003. Kinetics of antibody responses to Plasmodium falciparum-infected erythrocyte variant surface antigens. J. Infect. Dis. 187:667-674.
26. Kraemer, S. M., and J. D. Smith. 2003. Evidence for the importance of genetic structuring to the structural and functional specialization of the Plasmodium falciparum var gene family. Mol. Microbiol. 50:1527-1538.
27. Lambros, C., and J. P. Vanderberg. 1979. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65:418-420.
28. Lavstsen, T., A. Salanti, A. T. Jensen, D. E. Arnot, and T. G. Theander. 2003. Sub-grouping of Plasmodium falciparum 3D7 var genes based on sequence analysis of coding and non-coding regions. Malar. J. 2:27.
29. Lawrence, G., Q. Q. Cheng, C. Reed, D. Taylor, A. Stowers, N. Cloonan, C. Rzepczyk, A. Smillie, K. Anderson, D. Pombo, A. Allworth, D. Eisen, R. Anders, and A. Saul. 2000. Effect of vaccination with 3 recombinant asexual-stage malaria antigens on initial growth rates of Plasmodium falciparum in non-immune volunteers. Vaccine 18:1925-1931.
30. Lucas, A. O., R. G. Hendrickse, O. A. Okubadejo, W. H. Richards, R. A. Neal, and B. A. Kofie. 1969. The suppression of malarial parasitaemia by pyrimethamine in combination with dapsone or sulphormethoxine. Trans. R. Soc. Trop. Med. Hyg. 63:216-229.
31. Marsh, K. 1992. Malaria - a neglected disease? Parasitology 104(Suppl.):S53-S69.
32. Marsh, K., L. Otoo, R. J. Hayes, D. C. Carson, and B. M. Greenwood. 1989. Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. Trans. R. Soc. Trop. Med. Hyg. 83:293-303.
33. Oguariri, R. M., S. Borrmann, M. Q. Klinkert, P. G. Kremsner, and J. F. Kun. 2001. High prevalence of human antibodies to recombinant Duffy binding-like alpha domains of the Plasmodium falciparum-infected erythrocyte membrane protein 1 in semi-immune adults compared to that in non-immune children. Infect. Immun. 69:7603-7609.
34. Peters, J., E. Fowler, M. Gatton, N. Chen, A. Saul, and Q. Cheng. 2002. High diversity and rapid changeover of expressed var genes during the acute phase of Plasmodium falciparum infections in human volunteers. Proc. Natl. Acad. Sci. USA 99:10689-10694.
35. Playfair, J. H. 1982. Immunity to malaria. Br. Med. Bull. 38:153-159.
36. Pombo, D. J., G. Lawrence, C. Hirunpetcharat, C. Rzepczyk, M. Bryden, N. Cloonan, K. Anderson, Y. Mahakunkijcharoen, L. B. Martin, D. Wilson, S. Elliott, S. Elliott, D. P. Eisen, J. B. Weinberg, A. Saul, and M. F. Good. 2002. Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. Lancet 360:610-617.
37. Reeder, J. C., A. F. Cowman, K. M. Davern, J. G. Beeson, J. K. Thompson, S. J. Rogerson, and G. V. Brown. 1999. The adhesion of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A is mediated by P. falciparum erythrocyte membrane protein 1. Proc. Natl. Acad. Sci. USA 96:5198-5202.
38. Roberts, D. J., A. G. Craig, A. R. Berendt, R. Pinches, G. Nash, K. Marsh, and C. I. Newbold. 1992. Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature 357:689-692.
39. Robinson, B. A., T. L. Welch, and J. D. Smith. 2003. Widespread functional specialization of Plasmodium falciparum erythrocyte membrane protein 1 family members to bind CD36 analysed across a parasite genome. Mol. Microbiol. 47:1265-1278.
40. Rowe, J. A., J. M. Moulds, C. I. Newbold, and L. H. Miller. 1997. P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 388:292-295.
41. Smith, J. D., C. E. Chitnis, A. G. Craig, D. J. Roberts, D. E. Hudson-Taylor, D. S. Peterson, R. Pinches, C. I. Newbold, and L. H. Miller. 1995. Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell 82:101-110.
42. Smith, J. D., G. Subramanian, B. Gamain, D. I. Baruch, and L. H. Miller. 2000. Classification of adhesive domains in the Plasmodium falciparum erythrocyte membrane protein 1 family. Mol. Biochem. Parasitol. 110:293-310.
43. Soares, I. S., M. G. da Cunha, M. N. Silva, J. M. Souza, H. A. Del Portillo, and M. M. Rodrigues. 1999. Longevity of naturally acquired antibody responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1. Am. J. Trop. Med. Hyg. 60:357-363.
44. Stowers, A., D. Taylor, N. Prescott, Q. Cheng, J. Cooper, and A. Saul. 1997. Assessment of the humoral immune response against Plasmodium falciparum rhoptry-associated proteins 1 and 2. Infect. Immun. 65:2329-2338.
45. Su, X. Z., V. M. Heatwole, S. P. Wertheimer, F. Guinet, J. A. Herrfeldt, D. S. Peterson, J. A. Ravetch, and T. E. Wellems. 1995. The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes. Cell 82:89-100.
46. Trager, W., and J. B. Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
47. Treutiger, C. J., A. Heddini, V. Fernandez, W. A. Muller, and M. Wahlgren. 1997. PECAM-1/CD31, an endothelial receptor for binding Plasmodium falciparum-infected erythrocytes. Nat. Med. 3:1405-1408.
48. Udomsangpetch, R., J. Todd, J. Carlson, and B. M. Greenwood. 1993. The effects of hemoglobin genotype and ABO blood group on the formation of rosettes by Plasmodium falciparum-infected red blood cells. Am. J. Trop. Med. Hyg. 48:149-153.
49. Voss, T. S., J. K. Thompson, J. Waterkeyn, I. Felger, N. Weiss, A. F. Cowman, and H. P. Beck. 2000. Genomic distribution and functional characterisation of two distinct and conserved Plasmodium falciparum var gene 5′ flanking sequences. Mol. Biochem. Parasitol. 107:103-115.